Clinical Trial

Serum FSH Levels During Controlled Ovarian Stimulation

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Follicle-stimulating hormone (FSH) plays a central role in controlled ovarian stimulation (COS) during in vitro fertilization (IVF) cycles. While baseline FSH is commonly used to assess ovarian reserve, the clinical significance of dynamic FSH changes during stimulation remains unclear. Limited evidence suggests that serum FSH levels during COS may reflect ovarian response and could be associated with follicular development and treatment outcomes, yet FSH is not routinely monitored throughout stimulation protocols. This prospective single-center cohort study aims to evaluate the dynamics of serum FSH levels during COS and to examine their association with ovarian response and IVF outcomes. Serum FSH, luteinizing hormone (LH) and estradiol (E2) will be measured at predefined time points during stimulation. Associations between FSH levels and oocyte yield, embryo development, and pregnancy outcomes will be analyzed to better understand the clinical relevance of FSH monitoring during IVF treatment.
Trial Details
NCT Number NCT07460674
Lead Sponsor McGill University Health Centre/Research Institute of the McGill University Health Centre
Conditions Female Subjects Undergoing Controlled Ovarian Hyperstimulation
Enrollment 500 participants
Start Date 2026-02-16
Primary Completion 2030-12 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-10